Concerned Women for America - CWA: GAO Report on Plan B Finds What Parents Would Want – FDA Handled Controversial Drug With Great Caution

Search for on

Thursday, March 18, 2010

Home

Click here

CWA: GAO Report on Plan B Finds What Parents Would Want – FDA Handled Controversial Drug With Great Caution 11/14/2005

Washington, D.C.—Concerned Women for America (CWA) commended the Food & Drug Administration for treating with great concern the application to make the morning-after pill Plan B available over-the-counter (OTC), as found in a report released today by the Government Accountability Office (GAO).

“Making Plan B over-the-counter would needlessly expose adolescents to risks and reduce access to health care to those in need of it,” said Wendy Wright, CWA’s Executive Vice President. “The debate is whether it should be available without a prescription. Barr Labs never bothered to adequately research whether it could be taken safely by the full population who would purchase it from drugstore shelves. And proponents make false claims – which their own studies refute – that it would halve the number of pregnancies and abortions.

“Thankfully, the FDA’s leadership did what others refused to do – consider whether a drug’s easy availability would present unique health risks to women and girls.

“The FDA was asked to make a high dose of a drug available OTC when the low dose requires a prescription. Doctors screen women for medical conditions before prescribing the morning-after pill and check for conditions that a woman may not realize she’s acquired which can lead to infertility and death.

“The FDA should consider that its decision to make a drug as easy to get as toothpaste could lead to a proliferation of deadly sexually transmitted diseases.”

Wendy Wright testified at the FDA Advisory Committee hearing on OTC for Plan B. CWA filed an extensive report earlier this month with the FDA, which argued that it lacks the authority to approve Plan B with an age restriction and that OTC status for Plan B would put women at medical risk.